Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,120 | -494 | -5,132 | -3,724 | -2,877 |
| Depreciation Amortization | 108 | 22 | 45 | 28 | 6 |
| Accounts receivable | -19 | -316 | -551 | -371 | -66 |
| Other Working Capital | -486 | -73 | -250 | -588 | -35 |
| Other Operating Activity | 990 | 818 | 3,126 | 1,852 | 1,108 |
| Operating Cash Flow | $-1,527 | $-43 | $-2,762 | $-2,803 | $-1,864 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -127 | -48 | -271 | -164 | -101 |
| Investing Cash Flow | $-127 | $-48 | $-271 | $-164 | $-101 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 100 | N/A | 100 |
| Debt Repayment | -52 | -50 | N/A | N/A | N/A |
| Common Stock Issued | 2,174 | 1,350 | 3,657 | 3,267 | 2,150 |
| Other Financing Activity | 1,269 | 210 | 199 | 76 | -10 |
| Financing Cash Flow | $3,391 | $1,510 | $3,956 | $3,343 | $2,240 |
| Exchange Rate Effect | -13 | -6 | -34 | -70 | -11 |
| Beginning Cash Position | 1,851 | 1,851 | 962 | 962 | 962 |
| End Cash Position | 3,575 | 3,264 | 1,851 | 1,268 | 1,226 |
| Net Cash Flow | $1,724 | $1,413 | $889 | $306 | $264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,527 | -43 | -2,762 | -2,803 | -1,864 |
| Capital Expenditure | -127 | -48 | -271 | -164 | -101 |
| Free Cash Flow | -1,654 | -91 | -3,033 | -2,967 | -1,965 |